Literature DB >> 21739015

Mucocutaneous Leishmaniasis: clinical markers in presumptive diagnosis.

João Luiz Cioglia Pereira Diniz1, Manoel Otávio da Rocha Costa, Denise Utsch Gonçalves.   

Abstract

UNLABELLED: Mucocutaneous Leishmaniasis (ML) can lead to serious sequela; however, early diagnosis can prevent complications. AIM: To evaluate clinical markers for the early diagnosis of ML.
MATERIALS AND METHODS: A series study of 21 cases of ML, which were evaluated through clinical interview, nasal endoscopy, biopsy and the Montenegro test.
RESULTS: A skin scar and previous diagnosis of cutaneous leishmaniasis (CL) were reported in 8(38%) patients, and 13(62%) of them denied having had previous CL and had no scar. Nasal/oral symptom onset until the ML diagnosis varied from 5 months to 20 years, mean value of 6 years. In the Montenegro test, the average size of the papule was 14.5 mm, which did not correlate with disease duration (p=0.87). The nose was the most often involved site and the extension of the injured mucosa did not correlate with disease duration. The parasite was found in 2 (9.52%) biopsy specimens.
CONCLUSIONS: ML diagnosis was late. Finding the parasite in the mucosa, cutaneous scar and/or previous diagnosis of CL were not clinical markers for ML. ML diagnosis must be based on the Montenegro test, chronic nasal and/or oral discharge and histological findings ruling out other granulomatous diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21739015      PMCID: PMC9443764          DOI: 10.1590/s1808-86942011000300018

Source DB:  PubMed          Journal:  Braz J Otorhinolaryngol        ISSN: 1808-8686


  12 in total

1.  [The laboratory diagnosis and epidemiology of cutaneous leishmaniasis in Paraná State, southern Brazil].

Authors:  T G Silveira; S M Arraes; D A Bertolini; U Teodoro; M V Lonardoni; A C Roberto; M Ramos; A Nerilo Sobrinho; E Ishikawa; J Shaw
Journal:  Rev Soc Bras Med Trop       Date:  1999 Jul-Aug       Impact factor: 1.581

2.  Mucosal leishmaniasis.

Authors:  José Roberto Lambertucci; René Coulaud; Luciana Cristina dos Santos Silva
Journal:  Rev Soc Bras Med Trop       Date:  2003-06-10       Impact factor: 1.581

3.  Concomitant early mucosal and cutaneous leishmaniasis in Brazil.

Authors:  Viviane S Boaventura; Virginia Cafe; Jackson Costa; Fabiano Oliveira; Andre Bafica; Andrea Rosato; Luiz A R de Freitas; Claudia Brodskyn; Manoel Barral-Netto; Aldina Barral
Journal:  Am J Trop Med Hyg       Date:  2006-08       Impact factor: 2.345

4.  [American cutaneous leishmaniasis in the State of Acre, Brazil].

Authors:  N S Silva; A B Viana; J A Cordeiro; C E Cavasini
Journal:  Rev Saude Publica       Date:  1999-12       Impact factor: 2.106

5.  Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis.

Authors:  L P Carvalho; S Passos; O Bacellar; M Lessa; R P Almeida; A Magalhães; W O Dutra; K J Gollob; P Machado; A Ribeiro de Jesus
Journal:  Parasite Immunol       Date:  2007-05       Impact factor: 2.280

6.  [Outbreak of American cutaneous leishmaniasis in Canoa, Santo Amaro, Bahia, Brazil].

Authors:  I Follador; C Araujo; M A Cardoso; J Tavares-Neto; A Barral; J C Miranda; A Bittencourt; E M Carvalho
Journal:  Rev Soc Bras Med Trop       Date:  1999 Sep-Oct       Impact factor: 1.581

7.  Polymerase chain reaction with two molecular targets in mucosal leishmaniasis' diagnosis: a validation study.

Authors:  Clemencia Ovalle Bracho; Luisa Porras de Quintana; Sandra Muvdi Arenas; Melania Rios Parra
Journal:  Mem Inst Oswaldo Cruz       Date:  2007-08       Impact factor: 2.743

Review 8.  Mucosal leishmaniasis due to Leishmania (Viannia) braziliensis L(V)b in Três Braços, Bahia-Brazil.

Authors:  P D Marsden
Journal:  Rev Soc Bras Med Trop       Date:  1994 Apr-Jun       Impact factor: 1.581

9.  [Outbreak of American cutaneous leishmaniasis in Itaporanga, São Paulo (Brazil)].

Authors:  H O Stolf; S A Marques; M E Marques; E L Yoshida; N L Dillon
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1993 Sep-Oct       Impact factor: 1.846

Review 10.  Mucosal leishmaniasis: epidemiological and clinical aspects.

Authors:  Marcus Miranda Lessa; Hélio Andrade Lessa; Thomas W N Castro; Adja Oliveira; Albert Scherifer; Paulo Machado; Edgar M Carvalho
Journal:  Braz J Otorhinolaryngol       Date:  2007 Nov-Dec
View more
  12 in total

1.  Use of a clinical tool for screening and diagnosis of cutaneous leishmaniasis in Sri Lanka.

Authors:  H V Y D Siriwardana; U Senarath; P H Chandrawansa; N D Karunaweera
Journal:  Pathog Glob Health       Date:  2015-07-16       Impact factor: 2.894

2.  Progress of Mucocutaneous Leishmaniasis to Drug Nonresponsive Diffuse Cutaneous Leishmaniasis in Ethiopia. A Case Report.

Authors:  Banchamlak Tegegne; Getaneh Alemu
Journal:  Int Med Case Rep J       Date:  2020-10-20

3.  Differentiation of mucosal lesions in mucocutaneous leishmaniasis and paracoccidioidomycosis.

Authors:  Creuza Rachel Vicente; Aloisio Falqueto
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

4.  Autochthonous Cases of Mucosal Leishmaniasis in Northeastern Italy: Clinical Management and Novel Treatment Approaches.

Authors:  Valeria Gaspari; Irene Zaghi; Giovanni Macrì; Annalisa Patrizi; Nunzio Salfi; Francesca Locatelli; Elena Carra; Maria Carla Re; Stefania Varani
Journal:  Microorganisms       Date:  2020-04-18

5.  A prospective cohort study of Cutaneous Leishmaniasis due to Leishmania major: Dynamics of the Leishmanin skin test and its predictive value for protection against infection and disease.

Authors:  Jihène Bettaieb; Amine Toumi; Wissem Ghawar; Sadok Chlif; Mariem Nouira; Nabil Belhaj-Hamida; Adel Gharbi; Nissaf Ben-Alaya; Dhafer Laouini; Hechmi Louzir; Koussay Dellagi; Afif Ben Salah
Journal:  PLoS Negl Trop Dis       Date:  2020-08-25

6.  Chromosome-Level Genome Sequence of Leishmania (Leishmania) tropica Strain CDC216-162, Isolated from an Afghanistan Clinical Case.

Authors:  Yvette Unoarumhi; Dhwani Batra; Mili Sheth; Vidhya Narayanan; Wuling Lin; Yueli Zheng; Lori A Rowe; Jan Pohl; Marcos de Almeida
Journal:  Microbiol Resour Announc       Date:  2021-05-20

7.  Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.

Authors:  Hélio Galdino; Anetícia Eduarda Maldaner; Lívia Lara Pessoni; Frederico M Soriani; Ledice Inácia de Araújo Pereira; Sebastião Alves Pinto; Fernanda Bugalho Duarte; Clayson Moura Gomes; Anna Karoline Aguiar Fleuri; Miriam Leandro Dorta; Milton Adriano Pelli de Oliveira; Mauro Martins Teixeira; Aline Carvalho Batista; Leo A B Joosten; Leda Quercia Vieira; Fátima Ribeiro-Dias
Journal:  BMC Infect Dis       Date:  2014-05-09       Impact factor: 3.090

8.  Applicability of kDNA-PCR for routine diagnosis of American tegumentary leishmaniasis in a tertiary reference hospital.

Authors:  Marcela M Satow; Edite H Yamashiro-Kanashiro; Mussya C Rocha; Luiza K Oyafuso; Rita C Soler; Paulo C Cotrim; José Angelo L Lindoso
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2013 Nov-Dec       Impact factor: 1.846

9.  Voice disorders in mucosal leishmaniasis.

Authors:  Ana Cristina Nunes Ruas; Márcia Mendonça Lucena; Ananda Dutra da Costa; Jéssica Rafael Vieira; Maria Helena de Araújo-Melo; Benivaldo Ramos Ferreira Terceiro; Tania Salgado de Sousa Torraca; Armando de Oliveira Schubach; Claudia Maria Valete-Rosalino
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

Review 10.  Orphan diseases of the nose and paranasal sinuses: Pathogenesis - clinic - therapy.

Authors:  Martin Laudien
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.